Briefing: Federal vaccine adviser departs ACIP
Strategic angle: Robert Malone, an outspoken doctor and ally of RFK Jr., is stepping away from a panel of federal vaccine advisers after a federal judge blocked the panel’s work.
Latest Medicine stories from Life.
Strategic angle: Robert Malone, an outspoken doctor and ally of RFK Jr., is stepping away from a panel of federal vaccine advisers after a federal judge blocked the panel’s work.
Strategic angle: Comments from a top Trump administration health official highlight significant issues in the president’s drug pricing plans.
Strategic angle: Penn Engineers have redesigned a key component of lipid nanoparticles to enhance targeting and reduce off-target effects.
Strategic angle: Diverging messages on the main effort to address U.S. drug prices point to a loophole in Trump's plan.
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but it could eventually — affecting prices.
Strategic angle: New results on Pfizer's Lyme disease vaccine raise questions about its regulatory approval.
Strategic angle: A new vaccine shows some promise in combating Lyme disease, which affects nearly half a million Americans annually.
Strategic angle: India has dispatched 2.5 tons of emergency medical supplies to Kabul following a recent airstrike.
Strategic angle: Prosecutors allege drug transactions were found on Crimson Tide basketball star Aden Holloway's phone after his arrest on a felony drug charge.
Colombian President Gustavo Petro is under scrutiny by US federal prosecutors for alleged connections to drug trafficking.
Strategic angle: The Trump administration faces a pivotal decision on vaccine policymaking following a court ruling, with potential political ramifications.
Strategic angle: If the U.S. wants to hold on to its title as the world's top biotech innovator, it might want to take a page out of China's book.
Strategic angle: The Trump administration is counting on its drug pricing efforts to help with the midterm elections.
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval.
In today's Morning Rounds newsletter, a Texas couple getting rich off out-of-network medical bills, two doctors on the challenges of medicine today, and more.
Strategic angle: An analysis of the implications of the Jalisco cartel's leadership change on US drug policy.
Strategic angle: European activists provided crucial medical supplies to Cuba amidst a severe economic crisis exacerbated by a US energy blockade.
Strategic angle: Nursing homes misuse antipsychotic drugs for dementia patients, disguising the practice as schizophrenia treatment, a watchdog finds.
Strategic angle: Reform UK leader praises efforts to free imprisoned rapper and drug trafficker.
Strategic angle: Ilia II was hospitalised on Tuesday morning in critical condition with "mass bleeding from the stomach," the director of the Caucasus Medical Centre said.